While still a “card-carrying pharmacologist” today, Dr. Nicolette Louissaint points out proudly, the trained chemical engineer, with an accomplished academic background in biological and molecular sciences, has always had a superseding draw to biomedical research in the context of finding […]
Read MoreDirectors of the top sickle cell disease (SCD) programs in the US recently published the first set of recommendations for establishing SCD centers aimed at improving access to care for adults living with the debilitating, lifelong blood disease. The recommendations, which resulted from a […]
Read MoreSince its reign of terror began in the early 1980s, human immunodeficiency virus (HIV) has infected at least 76 million people worldwide. According to the World Health Organization (WHO), by the end of 2017, HIV-related disease had claimed 35 million […]
Read More
On the eve of the Am. Soc. of Clinical Oncologists meeting (June 1-5, Chicago), IQVIA has released its annual review of drug development and spending in oncology, Global Oncology Trends 2018. The topline finding is that global spending (therapeutic and […]
Read More
The 14th edition EMD Serono’s Specialty Digest continues its insights into the worries of pharmacy directors at managed care organizations and health plans. This year, the Digest took a particular look at multiple sclerosis (one of EMD Serono’s product areas) […]
Read More
Sped along by a priority review and breakthrough-therapy designation by FDA, Luxturna (voretigene neparvovec-rzyl), was approved on Dec. 19 for “confirmed biallelic RPE65 mutation-associated retinal dystrophy.” Retinal dystrophies, caused by a variety of genetic factors, cause a progressive lost of […]
Read More
Some 62.5% of American adults have what can be defined as a “pre-existing condition,” equal to an “astonishing” 152 million citizens, according to this year’s Global Health and Wellness Survey. That statistic—not widely recognized—could have been a factor in the […]
Read MoreIn the United States, a rare disease is defined as a condition that affects fewer than 200,000 people, while in the European Union, a disease is defined as rare when it affects fewer than one in 2,000 people. The US […]
Read More
Hoping to create a landmark change in direction of treatment for alcohol and drug addictions comparable to the 1964 report on cigarette smoking, the US Surgeon General has issued a report, Facing Addiction in America: The Surgeon General’s Report on […]
Read More
A handful of genetic tests are required by FDA, especially in new oncolytics, as companion diagnostics for prescribing certain drugs; the genetic testing identifies patients especially well suited to the drug (or, conversely, known to be poorly affected). But there […]
Read More
